These results might suggest different sensitivities of colon (cancer) cells toward distinct estrogenic substances or likely reflect different GPER1-mediated signaling pathways potentially activated by varied estrogenic and anti-estrogenic GPER1 binders. Here, GPER1 is linked to cancer.